Sphingomyelin synthase 2 overexpression promotes cisplatin‑induced apoptosis of HepG2 cells

Luo,Si; Pan,Zhen; Liu,Shuang; Yuan,Shujing; Yan,Nianlong

doi:10.3892/ol.2017.7309

Sphingomyelin synthase 2 overexpression promotes cisplatin‑induced apoptosis of HepG2 cells

Authors:
- Si Luo
- Zhen Pan
- Shuang Liu
- Shujing Yuan
- Nianlong Yan
View Affiliations

Affiliations: Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Nanchang University, Nanchang, Jiangxi 330006, P.R. China
Published online on: October 31, 2017 https://doi.org/10.3892/ol.2017.7309
Pages: 483-488

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Hepatoblastoma (HB) is the most type of common pediatric liver cancer. The primary chemotherapy drug for HB is cisplatin (DDP). However, patients readily develop intrinsic and acquired resistance, and severe side effects to treatment. Sphingomyelin synthase 2 (SMS2) is a key enzyme involved in the generation of sphingomyelin (SM), which is able to regulate cell proliferation, apoptosis and differentiation. The death receptors (DRs) have important functions in DDP‑induced apoptosis. However, whether SMS2 is able to modulate cell apoptosis through the DR signaling pathway remains unknown. To investigate this question, SMS2 was overexpressed in HepG2 cells and treated with 3.5 mg/l cisplatin in the present study. After 24 h, the expression of SMS2, avian myelocytomatosis viral oncogene homolog (c‑Myc), DR4, DR5 and caspase‑3 was analyzed. Furthermore, cell viability was quantified, and apoptosis was assessed by western blot and flow cytometry analysis as well as Cell Counting kit‑8. The results of the present study revealed that overexpression of SMS2 was able to increase the expression of c‑Myc, cleaved caspase‑3, DR4 and DR5 compared with the control group (P<0.05, n=3), and increase the levels of apoptosis in the SMS2 + DDP group, compared with the control (P<0.001, n=3). These results indicate that overexpression of SMS2 is able to improve sensitivity of HepG2 cells to DDP by increasing the expression of c‑Myc, DR4 and DR5 in HepG2 cells. This increased sensitivity may decrease intrinsic and acquired resistance of chemotherapy in HB, and reduce the associated severe side effects in pediatric patients.

View Figures

View References

1	Yuan XJ, Wang HM, Jiang H, Tang MJ, Li ZL, Zou X, Fang YJ, Pan C, Tou JF, Zhang KR, et al: Multidisciplinary effort in treating children with hepatoblastoma in China. Cancer Lett. 375:39–46. 2016. View Article : Google Scholar : PubMed/NCBI
2	van As JW, van den Berg H and van Dalen EC: Medical interventions for the prevention of platinum-induced hearing loss in children with cancer. Cochrane Database Syst Rev. 9:CD0092192016.PubMed/NCBI
3	Zhu S, Pabla N, Tang C, He L and Dong Z: DNA damage response in cisplatin-induced nephrotoxicity. Arch Toxicol. 89:2197–2205. 2015. View Article : Google Scholar : PubMed/NCBI
4	Fujikawa Y, Kawanishi M, Kuraoka I and Yagi T: Frequencies of mutagenic translesion DNA synthesis over cisplatin-guanine intra-strand crosslinks in lacZ plasmids propagated in human cells. Mutat Res Genet Toxicol Environ Mutagen. 770:23–28. 2014. View Article : Google Scholar : PubMed/NCBI
5	Chipuk JE, Kuwana T, Bouchier-Hayes L, Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science. 303:1010–1014. 2004. View Article : Google Scholar : PubMed/NCBI
6	Vondálová Blanárová O, Jelínková I, Szöor A, Skender B, Soucek K, Horváth V, Vaculová A, Andera L, Sova P, Szöllosi J, et al: Cisplatin and a potent platinum(IV) complex-mediated enhancement of TRAIL-induced cancer cells killing is associated with modulation of upstream events in the extrinsic apoptotic pathway. Carcinogenesis. 32:42–51. 2011. View Article : Google Scholar : PubMed/NCBI
7	Zhu X, Zhang K, Wang Q, Chen S, Gou Y, Cui Y and Li Q: Cisplatin-mediated c-Myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase-3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin. Med Oncol. 32:1332015. View Article : Google Scholar : PubMed/NCBI
8	Song JH, Tse MC, Bellail A, Phuphanich S, Khuri F, Kneteman NM and Hao C: Lipid rafts and non-rafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells. Cancer Res. 67:6946–6955. 2007. View Article : Google Scholar : PubMed/NCBI
9	Paul I, Chacko AD, Stasik I, Busacca S, Crawford N, McCoy F, McTavish N, Wilson B, Barr M, O'Byrne KJ, et al: Acquired differential regulation of caspase-8 in cisplatin-resistant non-small-cell lung cancer. Cell Death Dis. 3:e4492012. View Article : Google Scholar : PubMed/NCBI
10	Yeang C, Ding T, Chirico WJ and Jiang XC: Subcellular targeting domains of sphingomyelin synthase 1 and 2. Nutr Metab (Lond). 8:892011. View Article : Google Scholar : PubMed/NCBI
11	Taniguchi M and Okazaki T: The role of sphingomyelin and sphingomyelin synthases in cell death, proliferation and migration-from cell and animal models to human disorders. Biochim Biophys Acta. 1841:692–703. 2014. View Article : Google Scholar : PubMed/NCBI
12	Slotte JP: Biological functions of sphingomyelins. Prog Lipid Res. 52:424–437. 2013. View Article : Google Scholar : PubMed/NCBI
13	López-Terrada D, Cheung SW, Finegold MJ and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum Pathol. 40:1512–1515. 2009. View Article : Google Scholar
14	Yan N, Ding T, Dong J, Li Y and Wu M: Sphingomyelin synthase overexpression increases cholesterol accumulation and decreases cholesterol secretion in liver cells. Lipids Health Dis. 10:462011. View Article : Google Scholar : PubMed/NCBI
15	Huang CR, Jin ZX, Dong L, Tong XP, Yue S, Kawanami T, Sawaki T, Sakai T, Miki M, Iwao H, et al: cisplatin augments FAS-mediated apoptosis through lipid rafts. Anticancer Res. 30:2065–2071. 2010.PubMed/NCBI
16	Luberto C and Hannun YA: Sphingomyelin synthase, a potential regulator of intracellular levels of ceramide and diacylglycerol during SV40 transformation. Does sphingomyelin synthase account for the putative phosphatidylcholine-phospholipase C. J Biol Chem. 273:14550–14559. 1998. View Article : Google Scholar : PubMed/NCBI
17	Sumi T, Tsuneyoshi N, Nakatsuji N and Suemori H: Apoptosis and differentiation of human embryonic stem cells induced by sustained activation of c-Myc. Oncogene. 26:5564–5576. 2007. View Article : Google Scholar : PubMed/NCBI
18	Burns TA, Subathra M, Signorelli P, Choi Y, Yang X, Wang Y, Villani M, Bhalla K, Zhou D and Luberto C: Sphingomyelin synthase 1 activity is regulated by the BCR-ABL oncogene. J Lipid Res. 54:794–805. 2013. View Article : Google Scholar : PubMed/NCBI
19	Wesley UV, Hatcher JF and Dempsey RJ: Sphingomyelin synthase 1 regulates Neuro-2a cell proliferation and cell cycle progression through modulation of p27 expression and Akt signaling. Mol Neurobiol. 51:1530–1541. 2015. View Article : Google Scholar : PubMed/NCBI
20	Kim DY, Kim MJ, Kim HB, Lee JW, Bae JH, Kim DW, Kang CD and Kim SH: Suppression of multidrug resistance by treatment with TRAIL in human ovarian and breast cancer cells with high level of c-Myc. Biochim Biophys Acta. 1812:796–805. 2011. View Article : Google Scholar : PubMed/NCBI
21	Kondo K, Yamasaki S, Sugie T, Teratani N, Kan T, Imamura M and Shimada Y: Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma. Int J Cancer. 118:230–242. 2006. View Article : Google Scholar : PubMed/NCBI
22	Ding T, Li Z, Hailemariam T, Mukherjee S, Maxfield FR, Wu MP and Jiang XC: SMS overexpression and knockdown: Impact on cellular sphingomyelin and diacylglycerol metabolism, and cell apoptosis. J Lipid Res. 49:376–385. 2008. View Article : Google Scholar : PubMed/NCBI
23	Barceló-Coblijn G, Martin ML, de Almeida RF, Noguera-Salvà MA, Marcilla-Etxenike A, Guardiola-Serrano F, Lüth A, Kleuser B, Halver JE and Escribá PV: Sphingomyelin and sphingomyelin synthase (SMS) in the malignant transformation of glioma cells and in 2-hydroxyoleic acid therapy. Proc Natl Acad Sci. 108:pp. 19569–19574. 2011; View Article : Google Scholar : PubMed/NCBI
24	Simons K and Ikonen E: Functional rafts in cell membranes. Nature. 387:569–572. 1997. View Article : Google Scholar : PubMed/NCBI